NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.
Curebase offers the full package of robust services and tools built in-house to run clinical studies end-to-end that reach more patients through in-home, community-based, and site-based care.
- Trial Management- Data Management-Submissions-Remote Monitoring-Recruitment
-Virtual and Site-Based PIs - Local Practicioners- Mobile Nurses- Mobile Phlebotomists- In-house Research - Coordinators
- ePRO/eCOA- eConsent- Telemedicine- Screening- Scheduling- Site Portal- eSource- EDC